ACTRN12613000946718尚未招募2 期
Peg-interferon-alfa to achieve HBsAg loss in multi-drug resistance HBV under long-term viral suppression with tenofovir DF +/- lamivudine salvage therapy
Peter Angus0 个研究点目标入组 55 人开始时间: 2013年8月27日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •The initial TF109 has not been registered on ANZCTR. The initial 2 year data has been published by Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, et al. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 2011;60:247-54. The key inclusion criteria is that they have to have been involved in the initial TF109 study - on long term tenofovir DF.
排除标准
- •Severe liver disease which excludes them from peg-interferon therapy.
研究者
相似试验
尚未招募
2 期
A study of peginterferon-alfa intervention to achieve hepatitis B surface antigen loss in chronic hepatitis B participants under long-term viral suppression with nucleoside analoguesChronic Hepatitis BInfection - Other infectious diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615000915550Peter Angus50
Unknown
3 期
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis BChronic Hepatitis BAgHbs NegativationNCT01172392ANRS, Emerging Infectious Diseases185
已完成
4 期
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentChronic Hepatitis BNCT00226382Chinese University of Hong Kong50
已完成
3 期
The effect of Combination Peg interferon –alpha to Tenofovir versus each one of the treatment modalities alone on Patients with HBeAg-negative: A randomized clinical trialIRCT20181113041635N1vice presidency for siences and technology , Iran national silences foundation60
进行中（未招募）
1 期
Hepatitis B immunoglobulins to induce HBsAg clearance in patients with chronic hepatitis BEUCTR2021-005362-18-DEHannover Medical School20